2003
DOI: 10.1016/j.tem.2003.09.007
|View full text |Cite
|
Sign up to set email alerts
|

Activation of G-protein-coupled receptors: a common molecular mechanism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
149
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 172 publications
(153 citation statements)
references
References 62 publications
4
149
0
Order By: Relevance
“…These changes would be required for receptor activation and transduction of ligand binding to effector activation, for example. In fact, it is accepted that activation of GPCRs results from agonist-provoked changes in the conformation of the receptor that drives the equilibrium between the inactive and active state in favor of the latter (Gether and Kobilka, 1998;Karnik et al, 2003). The ability of ligands to change the shape of the receptor [and conversely of receptors to stabilize in distinct active conformations in response to different ligands (Lu et al, 2005)] and thereby transfer the signal to domains involved in G protein activation suggests that allosteric GPCR modulators (May et al, 2007) may be potential candidates for pharmacological chaperoning.…”
Section: Relation Between the Overall Receptor Structure And The Smentioning
confidence: 99%
“…These changes would be required for receptor activation and transduction of ligand binding to effector activation, for example. In fact, it is accepted that activation of GPCRs results from agonist-provoked changes in the conformation of the receptor that drives the equilibrium between the inactive and active state in favor of the latter (Gether and Kobilka, 1998;Karnik et al, 2003). The ability of ligands to change the shape of the receptor [and conversely of receptors to stabilize in distinct active conformations in response to different ligands (Lu et al, 2005)] and thereby transfer the signal to domains involved in G protein activation suggests that allosteric GPCR modulators (May et al, 2007) may be potential candidates for pharmacological chaperoning.…”
Section: Relation Between the Overall Receptor Structure And The Smentioning
confidence: 99%
“…Cys-109 forms a disulfide bond with Cys-188 in EC2, and disruption of the disulfide bond blocks ligand-dependent activation (13). This disulfide bond is found in over 91% of all human GPCRs and is important in many other receptors (19). Leu-112 was identified as an essential residue in TM3 (11), and a receptor with a L112A mutation failed to respond to C5a (18).…”
Section: First and Third Extracellular Loops Of C5armentioning
confidence: 99%
“…The G-protein-coupled receptor superfamily comprises the largest class of molecules involved in signal transduction across the plasma membrane, thus providing a mechanism of communication between the exterior and the interior of the cell (12,14) and represents *1% of the mammalian genome (15). It is estimated that up to 50% of clinically prescribed drugs act as either agonists or antagonists at GPCRs which points out their immense therapeutic potential (16). The serotonin 1A (5-HT 1A ) receptor is an important representative of this large family of receptors and is the most extensively studied of the serotonin receptors for a number of reasons (17,18).…”
Section: Introductionmentioning
confidence: 99%